UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 104

Sortiert nach

Conversion of unresponsiveness to immune checkpoint inhibition by fecal microbiota transplantation in patients with metastatic melanoma: study protocol for a randomized phase Ib/IIa trial

BMC cancer, 2022-12, Vol.22 (1), p.1366-11, Article 1366

2022

Volltextzugriff (PDF)

A real or apparent decrease in glomerular filtration rate in patients using olaparib?

European journal of clinical pharmacology, 2021-02, Vol.77 (2), p.179-188

2021

Volltextzugriff (PDF)

Discontinuation of proton pump inhibitors during assessment of chromogranin A levels in patients with neuroendocrine tumours

British journal of cancer, 2011-10, Vol.105 (8), p.1173-1175

2011

Volltextzugriff (PDF)

Lung and thymic carcinoids: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2021-04, Vol.32 (4), p.439-451

2021

Volltextzugriff (PDF)

Serum HE4 is correlated to prognostic factors and survival in patients with endometrial cancer

Virchows Archiv : an international journal of pathology, 2017-06, Vol.470 (6), p.655-664

2017

Volltextzugriff (PDF)

An elevated progastrin-releasing peptide level in patients with well-differentiated neuroendocrine tumours indicates a primary tumour in the lung and predicts a shorter survival

Annals of oncology, 2011-12, Vol.22 (12), p.2625-2630

2011

Volltextzugriff (PDF)

Two-protein signature of novel serological markers apolipoprotein-A2 and serum amyloid alpha predicts prognosis in patients with metastatic renal cell cancer and improves the currently used prognostic survival models

Annals of oncology, 2010-07, Vol.21 (7), p.1472-1481

2010

Volltextzugriff (PDF)

Role of natriuretic peptides in the diagnosis and treatment of patients with carcinoid heart disease

British journal of cancer, 2004-06, Vol.90 (11), p.2073-2079

2004

Volltextzugriff (PDF)

Safety of hormone replacement therapy following risk-reducing salpingo-oophorectomy: systematic review of literature and guidelines

Climacteric : the journal of the International Menopause Society, 2019-08, Vol.22 (4), p.352-360

2019

Volltextzugriff (PDF)

Can serum human epididymis protein 4 (HE4) support the decision to refer a patient with an ovarian mass to an oncology hospital?

Gynecologic oncology, 2022-08, Vol.166 (2), p.284-291

2022

Volltextzugriff (PDF)

Corrigendum to “Lung and thymic carcinoids: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up”: [Annals of Oncology 32 (2021) 439–451]

Annals of oncology, 2021-11, Vol.32 (11), p.1453-1455

2021

Volltextzugriff (PDF)

Impact of risk-reducing salpingo-oophorectomy in premenopausal women

Climacteric : the journal of the International Menopause Society, 2017-06, Vol.20 (3), p.212-221

2017

Volltextzugriff (PDF)

Impact of risk-reducing salpingo-oophorectomy on lipid determinants, HbA1c and CRP

Climacteric : the journal of the International Menopause Society, 2023-10, Vol.ahead-of-print (ahead-of-print), p.1-8

2023

Volltextzugriff (PDF)

Diagnostic validation and interpretation of longitudinal circulating biomarkers using a biomarker response characteristic plot

Clinica chimica acta, 2018-12, Vol.487, p.6-14

2018

Volltextzugriff (PDF)

Serum human epididymal protein 4 (HE4) as biomarker for the differentiation between epithelial ovarian cancer and ovarian metastases of gastrointestinal origin

Gynecologic oncology, 2015-03, Vol.136 (3), p.562-566

2015

Volltextzugriff (PDF)

A predictive model combining human epididymal protein 4 and radiologic features for the diagnosis of ovarian cancer

Gynecologic oncology, 2014-03, Vol.132 (3), p.573-577

2014

Volltextzugriff (PDF)

The luminescence immunoassay S-100: a sensitive test to measure circulating S-100B: its prognostic value in malignant melanoma

British journal of cancer, 1998-06, Vol.77 (12), p.2210-2214

1998

Volltextzugriff (PDF)

Does anti-Müllerian hormone predict change in menopausal symptoms following risk-reducing salpingo-oophorectomy? A prospective observational study

Climacteric : the journal of the International Menopause Society, 2018-11, Vol.21 (6), p.574-580

2018

Volltextzugriff (PDF)

EP906 Pre-operative prediction of residual disease after interval debulking surgery for advanced stage epithelial ovarian cancer using a multivariable model with HE4

International journal of gynecological cancer, 2019-11, Vol.29 (Suppl 4), p.A488-A488

2019

Volltextzugriff (PDF)

Serum S100B is suitable for prediction and monitoring of response to chemoimmunotherapy in metastatic malignant melanoma

Melanoma research, 2003-02, Vol.13 (1), p.45-49

2003

Volltextzugriff (PDF)

Comparison of four different assays for determination of serum S-100B

The International journal of biological markers, 2005, Vol.20 (1), p.34-42

2005

Volltextzugriff (PDF)

Can Initial Serum Cyfra 21-1, SCC Antigen, and TPA Levels in Squamous Cell Cervical Cancer Predict Lymph Node Metastases or Prognosis?

Gynecologic oncology, 2000-04, Vol.77 (1), p.164-170

2000

Volltextzugriff (PDF)

New biomarkers in epithelial ovarian cancer: needed or redundant?

European journal of gynaecological oncology, 2017, Vol.38 (3), p.356-360

2017

Volltextzugriff (PDF)

Pharmacokinetics of doxorubicin and cisplatin used in intraoperative hyperthermic intrathoracic chemotherapy after cytoreductive surgery for malignant pleural mesothelioma and pleural thymoma

Anti-cancer drugs, 2003-01, Vol.14 (1), p.57-65

2003

Volltextzugriff (PDF)

Prognostic value of the serum tumour markers Cyfra 21-1 and tissue polypeptide antigen in malignant mesothelioma

Lung cancer (Amsterdam, Netherlands), 1999-07, Vol.25 (1), p.25-32

1999

Volltextzugriff (PDF)

1 – 25 von 104

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(86)
Mit Volltextzugriff
(87)

Publikationsform

Artikel
(103)
Tagungsberichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Conversion of unresponsiveness to immune checkpoint inhibition by fecal microbiota transplantation in patients with metastatic melanoma: study protocol for a randomized phase Ib/IIa trial

A real or apparent decrease in glomerular filtration rate in patients using olaparib?

Discontinuation of proton pump inhibitors during assessment of chromogranin A levels in patients with neuroendocrine tumours

Lung and thymic carcinoids: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Serum HE4 is correlated to prognostic factors and survival in patients with endometrial cancer

An elevated progastrin-releasing peptide level in patients with well-differentiated neuroendocrine tumours indicates a primary tumour in the lung and predicts a shorter survival

Two-protein signature of novel serological markers apolipoprotein-A2 and serum amyloid alpha predicts prognosis in patients with metastatic renal cell cancer and improves the currently used prognostic survival models

Role of natriuretic peptides in the diagnosis and treatment of patients with carcinoid heart disease

Safety of hormone replacement therapy following risk-reducing salpingo-oophorectomy: systematic review of literature and guidelines

Can serum human epididymis protein 4 (HE4) support the decision to refer a patient with an ovarian mass to an oncology hospital?

Corrigendum to “Lung and thymic carcinoids: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up”: [Annals of Oncology 32 (2021) 439–451]

Impact of risk-reducing salpingo-oophorectomy in premenopausal women

Impact of risk-reducing salpingo-oophorectomy on lipid determinants, HbA1c and CRP

Diagnostic validation and interpretation of longitudinal circulating biomarkers using a biomarker response characteristic plot

Serum human epididymal protein 4 (HE4) as biomarker for the differentiation between epithelial ovarian cancer and ovarian metastases of gastrointestinal origin

A predictive model combining human epididymal protein 4 and radiologic features for the diagnosis of ovarian cancer

The luminescence immunoassay S-100: a sensitive test to measure circulating S-100B: its prognostic value in malignant melanoma

Does anti-Müllerian hormone predict change in menopausal symptoms following risk-reducing salpingo-oophorectomy? A prospective observational study

EP906 Pre-operative prediction of residual disease after interval debulking surgery for advanced stage epithelial ovarian cancer using a multivariable model with HE4

Serum S100B is suitable for prediction and monitoring of response to chemoimmunotherapy in metastatic malignant melanoma

Comparison of four different assays for determination of serum S-100B

Can Initial Serum Cyfra 21-1, SCC Antigen, and TPA Levels in Squamous Cell Cervical Cancer Predict Lymph Node Metastases or Prognosis?

New biomarkers in epithelial ovarian cancer: needed or redundant?

Pharmacokinetics of doxorubicin and cisplatin used in intraoperative hyperthermic intrathoracic chemotherapy after cytoreductive surgery for malignant pleural mesothelioma and pleural thymoma

Prognostic value of the serum tumour markers Cyfra 21-1 and tissue polypeptide antigen in malignant mesothelioma

Suchergebnisse filtern